BULATO, CRISTIANA
 Distribuzione geografica
Continente #
NA - Nord America 2.940
AS - Asia 359
EU - Europa 359
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 6
AF - Africa 1
OC - Oceania 1
Totale 3.672
Nazione #
US - Stati Uniti d'America 2.932
SG - Singapore 165
CN - Cina 136
IT - Italia 113
SE - Svezia 55
FI - Finlandia 54
VN - Vietnam 38
DE - Germania 29
FR - Francia 26
GB - Regno Unito 26
UA - Ucraina 12
IN - India 11
IE - Irlanda 10
NL - Olanda 10
BR - Brasile 5
CH - Svizzera 5
EU - Europa 5
MX - Messico 5
ES - Italia 4
HK - Hong Kong 4
TW - Taiwan 4
BE - Belgio 3
CA - Canada 3
RU - Federazione Russa 3
RO - Romania 2
A1 - Anonimo 1
AU - Australia 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
JP - Giappone 1
PL - Polonia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.672
Città #
Fairfield 491
Woodbridge 335
Chandler 286
Ashburn 214
Seattle 192
Houston 190
Ann Arbor 177
Cambridge 176
Wilmington 135
Singapore 129
Santa Clara 88
Boardman 71
San Diego 61
Princeton 49
Padova 46
Jacksonville 44
Des Moines 43
Beijing 37
Dong Ket 37
Medford 37
Helsinki 35
Roxbury 24
Nanjing 13
London 12
Milan 11
New York 9
Norwalk 8
Dublin 7
Hebei 7
Guangzhou 6
Nanchang 6
Pune 6
Falls Church 5
Los Angeles 5
Redwood City 5
Hong Kong 4
Kilburn 4
Kunming 4
Taipei 4
Chiampo 3
De Zilk 3
Detroit 3
Falkenstein 3
Jinan 3
Kharkiv 3
Mexico 3
Naples 3
Shanghai 3
Shenyang 3
Tianjin 3
Washington 3
Adligenswil 2
Bassano Del Grappa 2
Bologna 2
Cardano al Campo 2
Chicago 2
Dallas 2
Gurgaon 2
Hefei 2
Jiaxing 2
Lanzhou 2
North Bergen 2
Nürnberg 2
Ogden 2
Piacenza 2
Rome 2
Santa Ursula 2
Segovia 2
Taizhou 2
Uberlândia 2
Waanrode 2
Adliswil 1
Atlanta 1
Basel 1
Berlin 1
Bern 1
Borås 1
Bratislava 1
Brussels 1
Cairo 1
Changsha 1
Chiswick 1
Clifton 1
Cona 1
Dalian 1
Delhi 1
Denver 1
Dubbo 1
Dunavarsány 1
Edinburgh 1
Foggia 1
Fortaleza 1
Granby 1
Groningen 1
Hanoi 1
Iasi 1
Islington 1
Lappeenranta 1
Las Vegas 1
Madrid 1
Totale 3.118
Nome #
The thioredoxin specificity of Drosophila GPx: A paradigm for a peroxiredoxin-like mechanism of many glutathione peroxidases 167
Dynamics of circulating microparticles in obesity after weight loss 154
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 131
X-linked thrombophilia with a mutant factor IX (factor IX Padua). 124
Platelet factor V levels in moderate to severe congenital factor V deficiency. 118
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S 117
Whole blood rotation thromboelastometry (ROTEM(®)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V. 114
Factor IX activity/antigen ratio and the risk of first unprovoked venous thromboembolism. 112
Effect of mercury on selenium utilization and selenoperoxidase activity in LNCaP cells 111
Studies on coagulation incompatibilities for xenotransplantation. 110
New prothrombin mutation (Arg596Trp, Prothrombin Padua 2) associated with venous thromboembolism 107
Effects of long-term administration of recombinant human protein C in xenografted primates. 107
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. 107
Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency 99
Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study 99
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 97
Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes. 96
Peculiar laboratory phenotype/ genotype relationship due to compound inherited protein C defects in a child with severe venous thromboembolism 96
“In vitro” correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate 93
Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features 88
Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation. 87
Reference values for thromboelastometry (ROTEM®) in cynomolgus monkeys (Macaca fascicularis). 86
Identification of a novel frameshift mutation causing a premature stop codon in a young Nigerian man with type I antithrombin deficiency. 83
Thromboelastometry profiles after “in vitro” addition of a new plasma-derived factor V concentrate to whole blood from parahaemophilia patients 82
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis 81
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 75
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study 73
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 72
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis 71
Characterisation of the serotonin efflux induced by cytosolic Ca2+ and Na+ concentration increase in human platelets 65
Whole blood coagulation assessment using novel rotational thromboelastometry (ROTEM-R) in seen naive cynomologus monkeys 62
PTPepsilon has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells. 60
Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet! 60
Thrombin generation and thromboelastometry in monitoring the in-vitro reversal of warfarin: A comparison between 3-factor and 4-factor prothrombin complex concentrates 58
Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure 57
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC 42
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 40
Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis 40
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19 40
Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections 36
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 30
Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death 27
Whole blood thrombin generation shows a significant hypo-coagulable state in patients with decompensated cirrhosis 19
Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis 18
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 18
Protein C or Protein S deficiency associates with paradoxically impaired platelet-dependent thrombus and fibrin formation under flow 17
Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation 17
Cryptogenic ischemic stroke in cardiac transthyretin amyloidosis and sinus rhythm: a case report 16
Crucial roles of red blood cells and platelets in whole blood thrombin generation 14
Impaired whole blood thrombin generation is associated with procedure-related bleeding in acutely decompensated cirrhosis 11
von Willebrand factor in hospitalized patients with acute decompensation of cirrhosis is increased but not associated with development of ACLF 10
von Willebrand factor does not predict short-term mortality in ACLF 5
Totale 3.719
Categoria #
all - tutte 16.488
article - articoli 16.488
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020339 0 0 0 0 0 0 69 79 80 53 29 29
2020/2021599 12 45 39 56 46 28 28 52 74 66 67 86
2021/2022678 40 72 74 34 32 68 39 60 33 28 65 133
2022/2023539 90 73 7 77 84 80 6 37 59 3 19 4
2023/2024294 10 46 35 35 24 50 20 3 3 16 22 30
2024/2025408 5 87 68 42 162 37 7 0 0 0 0 0
Totale 3.719